Precision medicine: the foundation of future cancer therapeutics

QR Code

Precision medicine: the foundation of future cancer therapeutics

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Seung Ho Shin, Ann M. Bode, Zigang Dong
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2017
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/bfa4019ac8c64cc186c83fa25d3a406a
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Precision oncology- the future of personalized cancer medicine?
par: Ann M. Bode, et autres
Publié: (2017)

Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?
par: Grannum R. Sant, et autres
Publié: (2017)

Targeting ornithine decarboxylase (ODC) inhibits esophageal squamous cell carcinoma progression
par: Wei He, et autres
Publié: (2017)

Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial
par: Holly Keane, et autres
Publié: (2021)

Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia
par: Mayumi Sugita, et autres
Publié: (2021)

Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study
par: Apostolia Maria Tsimberidou, et autres
Publié: (2021)

PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine
par: Mariaelena Pierobon, et autres
Publié: (2021)

Precision cell-free DNA extraction for liquid biopsy by integrated microfluidics
par: Hoyoon Lee, et autres
Publié: (2020)

Artificial intelligence for the next generation of precision oncology
par: Pedro J. Ballester, et autres
Publié: (2021)

Inhibiting breast cancer by targeting the thromboxane A2 pathway
par: Haitao Li, et autres
Publié: (2017)

Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
par: Feng Liu, et autres
Publié: (2017)

Circulating tumor cells: quintessential precision oncology presenting challenges for biology
par: Rebecca J. Morris
Publié: (2017)

Network-based machine learning and graph theory algorithms for precision oncology
par: Wei Zhang, et autres
Publié: (2017)

Structural variant detection in cancer genomes: computational challenges and perspectives for precision oncology
par: Ianthe A. E. M. van Belzen, et autres
Publié: (2021)

Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care
par: Ugljesa Djuric, et autres
Publié: (2017)

Correction: Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
Publié: (2021)

Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology
par: Frank P. Lin, et autres
Publié: (2021)

Breast reconstruction: current and future options
par: Paul Jr H, et autres
Publié: (2011)

A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial
par: Istvan Petak, et autres
Publié: (2021)

Swiss-PO: a new tool to analyze the impact of mutations on protein three-dimensional structures for precision oncology
par: Fanny S. Krebs, et autres
Publié: (2021)

Implications for breast cancer dormancy in other areas of medicine
par: Rameshwar P
Publié: (2012)

AXL receptor tyrosine kinase as a therapeutic target in NSCLC
par: Okimoto RA, et autres
Publié: (2015)

Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
par: Ashish Manne, et autres
Publié: (2021)

Challenges in the development of future treatments for breast cancer stem cells
par: Shyam A Patel, et autres
Publié: (2010)

Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival
par: Vladimir Lazar, et autres
Publié: (2021)

Epiregulin as a therapeutic target in non-small-cell lung cancer
par: Sunaga N, et autres
Publié: (2015)

PI3K mutations in breast cancer: prognostic and therapeutic implications
par: Mukohara T
Publié: (2015)

MET targeted therapy for lung cancer: clinical development and future directions
par: Feng Y, et autres
Publié: (2012)

Traditional Chinese Medicine Therapy for Esophageal Cancer: A Literature Review
par: Luchang Cao MB, et autres
Publié: (2021)

Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
par: Razan Alzeibak, et autres
Publié: (2021)

Emerging role of G9a in cancer stemness and promises as a therapeutic target
par: Joshua R. Haebe, et autres
Publié: (2021)

Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer
par: Zienolddiny S, et autres
Publié: (2011)

Therapeutic reduction mammoplasty in large-breasted women with cancer using superior and superomedial pedicles
par: Denewer A, et autres
Publié: (2012)

Safety and esthetic outcomes of therapeutic mammoplasty using medial pedicle for early breast cancer
par: Roshdy S, et autres
Publié: (2015)

Correction: Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
Publié: (2021)

Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine
par: Jane Bayani, et autres
Publié: (2017)

Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects
par: María Gion, et autres
Publié: (2021)

Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy
par: Yu BF, et autres
Publié: (2015)

Oral Chinese Patent Medicine Combined With Oxaliplatin-Based Chemotherapy Regimen for the Treatment of Colorectal Cancer: A Network Meta-Analysis
par: Mo Tang PhD Student, et autres
Publié: (2021)

Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target
par: Nathan D. Seligson, et autres
Publié: (2021)